Characterization of mouse serum tenascin-X

DNA and Cell Biology

Volumn 25, Issue 8, 2006, Pages 448-456

  Matsumoto, Ken Ichi ^a   Kinoshita, Takeshi ^a   Hirose, Tomohiro ^a   Ariga, Hiroyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; FIBRONECTIN TYPE III; PROTEINASE INHIBITOR; TENASCIN; TENASCIN X; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HOMOGENATE; MOLECULAR WEIGHT; MOUSE; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; SPLEEN; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; FEMALE; MICE; RABBITS; TENASCIN;

EID: 33747586763     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.25.448     Document Type: Article

References (27)

1. BRISTOW, J., TEE, M.K., GITELMAN, S.E., MELLON, S.H., and MILLER, W.L. (1993). Tenascin-X: A novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B, J. Cell Biol. 122, 265-278.
2. BURCH, G.H., GONG, Y., LIU, W., DETTMAN, R.W., CURRY, C.J., SMITH, L., MILLER, W.L., and BRISTOW, J. (1997). Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat. Genet. 17, 5-7.
3. CHIQUET-EHRISMANN, R., MACKIE, E.J., PEARSON, C.A., and SAKAKURA, T. (1986). Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47, 131-139.
4. FUSS, B., WINTERGERST, E.S., BARTSCH, U., and SCHACHNER, M. (1993). Molecular characterization and in situ mRNA localization of the neural recognition molecule J1-160/180: A modular structure similar to tenascin. J. Cell Biol. 120, 1237-1249.
5. HAGIOS, C., KOCH, M., SPRING, J., CHIQUET, M., and CHIQUET-EHRISMANN, R. (1996). Tenascin-Y: A protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue. J. Cell Biol. 134, 1499-1512.
6. HASEGAWA, K., YOSHIDA, T., MATSUMOTO, K., KATSUTA, K., WAGA, S., and SAKAKURA, T. (1997). Differential expression of tenascin-C and tenascin-X in human astrocytomas. Acta Neuropathol. 93, 431-437.
7. HERLYN, M., GRAEVEN, U., SPEICHER, D., SELA, B.A., BENNICELLI, J.L., KATH, R., and GUERRY, D. IV. (1991). Characterization of tenascin secreted by human melanoma cells. Cancer Res. 51, 4853-4858.
8. IKUTA, T., SOGAWA, N., ARIGA, H., IKEMURA, T., and MATSUMOTO, K. (1998). Structural analysis of mouse tenascin-X: Evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family. Gene 217, 1-13.
9. IKUTA, T., ARIGA, H., and MATSUMOTO, K. (2000). Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes Cells 5, 913-927.
10. IMANAKA-YOSHIDA, K., MATSUMOTO, K., HARA, M., SAKAKURA, T., and YOSHIDA, T. (2003). The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation 71, 291-298.
11. LETHIAS, C., DESCOLLONGES, Y., BOUTILLON, M.M., and GARRONE, R. (1996). Flexilin: A new extracellular matrix glycoprotein localized on collagen fibrils, Matrix Biol. 15, 11-19.
12. MATSUMOTO, K., ARAI, M., ISHIHARA, N., ANDO, A., INOKO, H., and IKEMURA, T. (1992). Cluster of fibronectin type III repeats found in the human major histocompatibility complex class III region shows the highest homology with the repeats in an extracellular matrix protein, tenascin. Genomics 12, 485-491.
13. MATSUMOTO, K., SAGA, Y., IKEMURA, T., SAKAKURA, T., and CHIQUET-EHRISMANN, R. (1994). The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J. Cell Biol. 125, 483-493.
14. MATSUMOTO, K., TAKAYAMA, N., OHNISHI, J., OHNISHI, E., SHIRAYOSHI, Y., NAKATSUJI, N., and ARIGA, H. (2001). Tumour invasion and metastasis are promoted in mice deficient in tenascin-X. Genes Cells 6, 1101-1111.
15. MINAMITANI, T., ARIGA, H., and MATSUMOTO, K. (2004a). Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. Exp. Cell Res. 297, 40-60.
16. MINAMITANI, T., IKUTA, T., SAITO, Y., TAKEBE, G., SATO, M., SAWA, H., NISHIMURA, T., NAKAMURA, F., TAKAHASHI, K., ARIGA, H., et al. (2004b). Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen. Exp. Cell Res. 298, 305-315.
17. MONGIAT, M., SWEENEY, S.M., SAN ANTONIO, J.D., FU, J., and IOZZO, R.V. (2003). Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278, 4238-4249.
18. MOREL, Y., BRISTOW, J., GITELMAN, S.E., and MILLER, W.L. (1989). Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. Proc. Natl. Acad. Sci. USA 86, 6582-6586.
19. NEIDHARDT, J., FEHR, S., KUTSCHE, M., LÖHLER, J., and SCHACHNER, M. (2003). Tenascin-N: Characterization of a novel member of the tenascin family that mediates neurite repulsion from hippocampal explants. Mol. Cell. Neurosci. 23, 193-209.
20. O'REILLY, M.S., HOLMGREN, L., SHING, Y., CHEN, C., ROSENTHAL, R.A., MOSES, M., LANE, W.S., CAO, Y., SAGE, E.H., and FOLKMAN, J. (1994). Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
21. O'REILLY, M.S., BOEHM, T., SHING, Y., FUKAI, N., VASIOS, G., LANE, W.S., FLYNN, E., BIRKHEAD, J.R., OLSEN, B.R., and FOLKMAN, J. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
22. SCHALKWIJK, J., ZWEERS, M.C., STEIJLEN, P.M., DEAN, W.B., TAYLOR, G., VAN VLIJMEN, I.M., VAN HAREN, B., MILLER, W.L., and BRISTOW, J. (2001). A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N. Engl. J. Med. 345, 1203-1205.
23. SCHERBERICH, A., TUCKER, R.P., SAMANDARI, E., BROWN-LUEDI, M., MARTIN, D., and CHIQUET-EHRISMANN, R. (2004). Murine tenascin-W: A novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development. J. Cell Sci. 117, 571-581.
24. WEBER, P., MONTAG, D., SCHACHNER, M., and BERNHARDT, R.R. (1998). Zebrafish tenascin-W, a new member of the tenascin family. J. Neurobiol. 35, 1-16.
25. YI, M., and RUOSLAHTI, E. (2001). A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc. Natl. Acad. Sci. USA 98, 620-624.
26. ZWEERS, M.C., HAKIM, A.J., GRAHAME, R., and SCHALKWIJK, J. (2004). Joint hypermobility syndromes: The pathophysiologic role of tenascin-X gene defects. Arthritis Rheum. 50, 2742-2749.
27. ZWEERS, M.C., PEETERS, A.C., GRAAFSMA, S., KRANENDONK, S., VAN DER VLIET, J.A., DEN HEUER, M., and SCHALKWIJK, J. (2006). Abdominal aortic aneurysm is associated with high serum levels of tenascin-X and decreased aneurysmal tissue tenascin-X. Circulation 113, 1702-1707.